期刊
CELLULAR MICROBIOLOGY
卷 7, 期 1, 页码 1-9出版社
WILEY
DOI: 10.1111/j.1462-5822.2004.00477.x
关键词
-
资金
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, U01AI058935, T32AI007061, R21AI053442, R01AI040725] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013523] Funding Source: NIH RePORTER
- NIAID NIH HHS [U54 AI057159, T32-AI07061, R21 AI053442, R01 AI40725, U01 AI58935, U01 AI058935] Funding Source: Medline
- NIDCR NIH HHS [R01 DE13523] Funding Source: Medline
In vivo induced antigen technology (IVIAT) is a technique that identifies pathogen antigens that are immunogenic and expressed in vivo during human infection. IVIAT is complementary to other techniques that identify genes and their products expressed in vivo. Genes and gene pathways identified by IVIAT may play a role in virulence or pathogenesis during human infection, and may be appropriate for inclusion in therapeutic, vaccine or diagnostic applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
